Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 2
1993 2
1995 1
1996 2
1997 1
1999 2
2000 2
2001 1
2002 3
2003 4
2004 2
2005 1
2008 2
2010 3
2011 2
2012 4
2013 5
2014 10
2015 5
2016 4
2017 5
2018 1
2019 8
2020 1
2021 3
2022 3
2023 3
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial.
Mankikian J, Caille A, Reynaud-Gaubert M, Agier MS, Bermudez J, Bonniaud P, Borie R, Brillet PY, Cadranel J, Court-Fortune I, Crestani B, Debray MP, Gomez E, Gondouin A, Hirschi-Santelmo S, Israel-Biet D, Jouneau S, Juvin K, Leger J, Kerjouan M, Marquette CH, Naccache JM, Nunes H, Plantier L, Prevot G, Quetant S, Traclet J, Valentin V, Uzunhan Y, Wémeau-Stervinou L, Bejan-Angoulvant T, Cottin V, Marchand-Adam S; EVER-ILD investigators and the OrphaLung network. Mankikian J, et al. Among authors: court fortune i. Eur Respir J. 2023 Jun 8;61(6):2202071. doi: 10.1183/13993003.02071-2022. Print 2023 Jun. Eur Respir J. 2023. PMID: 37230499 Free article. Clinical Trial.
Rituximab and mycophenolate mofetil in interstitial lung disease (EVER-ILD): 1-year follow-up results of a randomised controlled trial.
Mansy L, Caille A, Reynaud-Gaubert M, Bermudez J, Bonniaud P, Borie R, Brillet PY, Cadranel J, Court-Fortune I, Crestani B, Debray MP, Duprez M, Guillaumot A, Hirschi-Santelmo S, Israel-Biet D, Jouneau S, Juvin K, Kerjouan M, Mankikian J, Marquette CH, Naccache JM, Nunes H, Plantier L, Prevot G, Quetant S, Traclet J, Valentin V, Uzunhan Y, Wémeau-Stervinou L, Cottin V, Marchand-Adam S; EVER-ILD investigators and the OrphaLung network. Mansy L, et al. Among authors: court fortune i. Eur Respir J. 2024 Sep 12;64(3):2401368. doi: 10.1183/13993003.01368-2024. Print 2024 Sep. Eur Respir J. 2024. PMID: 39231630 Clinical Trial. No abstract available.
Phrenic Nerve Conduction in Healthy Subjects.
Vincent M, Court-Fortune I, Costes F, Antoine JC, Camdessanché JP. Vincent M, et al. Among authors: court fortune i. Muscle Nerve. 2019 Apr;59(4):451-456. doi: 10.1002/mus.26414. Epub 2019 Jan 24. Muscle Nerve. 2019. PMID: 30623462
French recommendations for the diagnosis and management of lymphangioleiomyomatosis.
Cottin V, Blanchard E, Kerjouan M, Lazor R, Reynaud-Gaubert M, Taille C, Uzunhan Y, Wemeau L, Andrejak C, Baud D, Bonniaud P, Brillet PY, Calender A, Chalabreysse L, Court-Fortune I, Desbaillets NP, Ferretti G, Guillemot A, Hardelin L, Kambouchner M, Leclerc V, Lederlin M, Malinge MC, Mancel A, Marchand-Adam S, Maury JM, Naccache JM, Nasser M, Nunes H, Pagnoux G, Prévot G, Rousset-Jablonski C, Rouviere O, Si-Mohamed S, Touraine R, Traclet J, Turquier S, Vagnarelli S, Ahmad K; OrphaLung network. Cottin V, et al. Among authors: court fortune i. Respir Med Res. 2023 Jun;83:101010. doi: 10.1016/j.resmer.2023.101010. Epub 2023 Mar 24. Respir Med Res. 2023. PMID: 37087906
Impact of gender on COPD expression in a real-life cohort.
Roche N, Deslée G, Caillaud D, Brinchault G, Court-Fortune I, Nesme-Meyer P, Surpas P, Escamilla R, Perez T, Chanez P, Pinet C, Jebrak G, Paillasseur JL, Burgel PR; INITIATIVES BPCO Scientific Committee. Roche N, et al. Among authors: court fortune i. Respir Res. 2014 Feb 17;15(1):20. doi: 10.1186/1465-9921-15-20. Respir Res. 2014. PMID: 24533770 Free PMC article.
Implanted Phrenic Stimulation Impairs Local Diaphragm Myofiber Reinnervation in Amyotrophic Lateral Sclerosis.
Guimarães-Costa R, Niérat MC, Rivals I, Morélot-Panzini C, Romero NB, Menegaux F, Salachas F, Gonzalez-Bermejo J, Similowski T, Bruneteau G; RespiStimALS team. Guimarães-Costa R, et al. Am J Respir Crit Care Med. 2019 Nov 1;200(9):1183-1187. doi: 10.1164/rccm.201903-0653LE. Am J Respir Crit Care Med. 2019. PMID: 31291123 Free article. No abstract available.
Home care organization impacts patient management and survival in ALS.
Lavernhe S, Antoine JC, Court-Fortune I, Dimier N, Costes F, Lacour A, Camdessanché JP. Lavernhe S, et al. Among authors: court fortune i. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):562-568. doi: 10.1080/21678421.2017.1332076. Epub 2017 Jun 6. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 28585472
Clinical COPD phenotypes identified by cluster analysis: validation with mortality.
Burgel PR, Roche N, Paillasseur JL, Tillie-Leblond I, Chanez P, Escamilla R, Court-Fortune I, Perez T, Carré P, Caillaud D; INITIATIVES BPCO Scientific Committee. Burgel PR, et al. Among authors: court fortune i. Eur Respir J. 2012 Aug;40(2):495-6. doi: 10.1183/09031936.00228511. Eur Respir J. 2012. PMID: 22855468 Free article. No abstract available.
75 results